ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,237Medicare Part D Prescriptions Filled, Including Refills

Rank: 203 out of 1000

$593K Total Retail Price of All Prescriptions

Rank: 200 out of 1000

605 Patients Receiving at Least One Drug in Part D
52%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 605 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 7,167 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 489 251 1 2
SIMVASTATIN 407 263 2 3
AMLODIPINE BESYLATE 342 245 3 6
PRAVASTATIN SODIUM 333 226 4 12
FUROSEMIDE 330 238 5 7
HYDROCHLOROTHIAZIDE 320 165 6 9
METFORMIN HCL 307 187 7 8
MELOXICAM 255 171 8 14
CARVEDILOL 249 168 9 15
WARFARIN SODIUM 236 178 10 22
TRAMADOL HCL 226 124 11 13
POTASSIUM CHLORIDE 214 168 12 10
NEXIUM 189 76 13 23
ACTOS 172 109 14 119
LEVOTHYROXINE SODIUM 172 123 14 4
CRESTOR 172 120 14 30
LISINOPRIL 160 111 17 5
GLIMEPIRIDE 158 114 18 34
METOPROLOL TARTRATE 157 113 19 19
DIOVAN HCT 151 84 20 96
KLOR-CON M20 150 109 21 66
CLONIDINE HCL 148 71 22 27
GABAPENTIN 139 91 23 11
LOSARTAN-HYDROCHLOROTHIAZIDE 117 75 24 38
SULFAMETHOXAZOLE-TRIMETHOPRIM 117 61 24 70
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 90 26 20
AMLODIPINE BESYLATE-BENAZEPRIL 107 56 27 59
DIGOXIN 101 50 28 52
ALLOPURINOL 100 66 29 31
IBUPROFEN 94 47 30 94
PHENYTOIN SODIUM EXTENDED 91 37 31 115
INSULIN SYRINGE 85 24 32 93
DIOVAN 82 69 33 67
METFORMIN HCL ER 82 32 33 44
LOSARTAN POTASSIUM 81 52 35 25
BUMETANIDE 80 49 36 112
TRAZODONE HCL 79 24 37 29
AZITHROMYCIN 79 37 37 36
NIFEDIPINE ER 75 57 39 130
ZOLPIDEM TARTRATE 74 0 40 16
VERAPAMIL ER 74 50 40 86
FAMOTIDINE 73 43 42 88
CLOPIDOGREL 73 42 42 35
BENICAR HCT 72 26 44 262
PIOGLITAZONE HCL 72 45 R 44 253
ATENOLOL 72 48 44 24
HYDROCODONE-ACETAMINOPHEN 70 57 S3 47 1
LANTUS 70 38 47 68
METOLAZONE 69 55 49 167
ATORVASTATIN CALCIUM 68 37 50 18
CLOTRIMAZOLE-BETAMETHASONE 63 13 51 173
METHYLPREDNISOLONE 62 36 52 103
HYDRALAZINE HCL 61 38 53 74
TRIAMTERENE-HCTZ 60 37 54 48
BUSPIRONE HCL 59 21 55 110
RANITIDINE HCL 58 38 56 37
KLOR-CON 10 58 27 56 104
NAPROXEN 58 39 56 81
PROAIR HFA 54 25 59 50
AMITRIPTYLINE HCL 52 18 R 60 45
BENAZEPRIL HCL 51 41 61 61
AMOXICILLIN 51 19 61 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.